Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5' part of the gene - PubMed (original) (raw)
Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5' part of the gene
G Danglot et al. Hum Mol Genet. 1995 May.
Abstract
The neurofibromatosis 1 gene seems to play essential roles at several different stages of life. During embryogenesis, it is involved in cardiac development while in the adult, neurofibromin (the corresponding protein) is mainly expressed in the nervous system, and therein, essentially in neurons, non-myelinating Schwann cells and oligodendrocytes. In addition, the NF1 gene is considered a tumor suppressor gene, since mutations have been associated with the occurrence of benign and malignant tumors in neuralcrest-derived tissues. Using reverse transcription-polymerase chain reaction (RT-PCR) analyses with primers located in exons 7 and 13, we have identified evidence of alternative splicing in this region of the NF1 gene. Cloning and sequencing of cDNA allowed the characterization of an isoform bearing an extra 30 bp sequence between exons 9 and 10a, leading to the insertion of 10 amino acids between residues 420 and 421 of neurofibromin. The insertion is conserved in the mouse. Examination of the pattern of expression of this isoform demonstrated a high level of expression in the central nervous system and an absence of expression in all the other normal tissues tested including peripheral nervous tissues derived from the neural crest. Analysis of brain tumors indicated a reduced expression of the alternative exon in medulloblastomas and oligodendrogliomas. The results presented here are consistent with tissue-specific expression of this alternative exon which we propose to call exon 9br.
Similar articles
- An alternatively-spliced mRNA in the carboxy terminus of the neurofibromatosis type 1 (NF1) gene is expressed in muscle.
Gutman DH, Andersen LB, Cole JL, Swaroop M, Collins FS. Gutman DH, et al. Hum Mol Genet. 1993 Jul;2(7):989-92. doi: 10.1093/hmg/2.7.989. Hum Mol Genet. 1993. PMID: 8364582 - Expression of the neurofibromatosis 1 (NF1) isoforms in developing and adult rat tissues.
Gutmann DH, Geist RT, Wright DE, Snider WD. Gutmann DH, et al. Cell Growth Differ. 1995 Mar;6(3):315-23. Cell Growth Differ. 1995. PMID: 7794799 - Analysis of an alternatively spliced exon of the neurofibromatosis type 1 gene in cultured melanocytes from patients with neurofibromatosis 1.
Eisenbarth I, Hoffmeyer S, Kaufmann D, Assum G, Krone W. Eisenbarth I, et al. Arch Dermatol Res. 1995;287(5):413-6. doi: 10.1007/BF00373420. Arch Dermatol Res. 1995. PMID: 7625848 - Molecular genetics of neurofibromatosis type 1 (NF1).
Shen MH, Harper PS, Upadhyaya M. Shen MH, et al. J Med Genet. 1996 Jan;33(1):2-17. doi: 10.1136/jmg.33.1.2. J Med Genet. 1996. PMID: 8825042 Free PMC article. Review. - Neurofibromatosis type 1 (NF1) gene: implication in neuroectodermal differentiation and genesis of brain tumors.
Nishi T, Saya H. Nishi T, et al. Cancer Metastasis Rev. 1991 Dec;10(4):301-10. doi: 10.1007/BF00554792. Cancer Metastasis Rev. 1991. PMID: 1786631 Review.
Cited by
- Deciphering Glioblastoma: Fundamental and Novel Insights into the Biology and Therapeutic Strategies of Gliomas.
Onciul R, Brehar FM, Toader C, Covache-Busuioc RA, Glavan LA, Bratu BG, Costin HP, Dumitrascu DI, Serban M, Ciurea AV. Onciul R, et al. Curr Issues Mol Biol. 2024 Mar 13;46(3):2402-2443. doi: 10.3390/cimb46030153. Curr Issues Mol Biol. 2024. PMID: 38534769 Free PMC article. Review. - RAS and beyond: the many faces of the neurofibromatosis type 1 protein.
Anastasaki C, Orozco P, Gutmann DH. Anastasaki C, et al. Dis Model Mech. 2022 Feb 1;15(2):dmm049362. doi: 10.1242/dmm.049362. Epub 2022 Feb 21. Dis Model Mech. 2022. PMID: 35188187 Free PMC article. - Neurofibromatosis Type 1 Gene Alterations Define Specific Features of a Subset of Glioblastomas.
Scheer M, Leisz S, Sorge E, Storozhuk O, Prell J, Ho I, Harder A. Scheer M, et al. Int J Mol Sci. 2021 Dec 29;23(1):352. doi: 10.3390/ijms23010352. Int J Mol Sci. 2021. PMID: 35008787 Free PMC article. Review. - Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.
Koster R, Brandão RD, Tserpelis D, van Roozendaal CEP, van Oosterhoud CN, Claes KBM, Paulussen ADC, Sinnema M, Vreeburg M, van der Schoot V, Stumpel CTRM, Broen MPG, Spruijt L, Jongmans MCJ, Lesnik Oberstein SAJ, Plomp AS, Misra-Isrie M, Duijkers FA, Louwers MJ, Szklarczyk R, Derks KWJ, Brunner HG, van den Wijngaard A, van Geel M, Blok MJ. Koster R, et al. NPJ Genom Med. 2021 Nov 15;6(1):95. doi: 10.1038/s41525-021-00258-w. NPJ Genom Med. 2021. PMID: 34782607 Free PMC article. - Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.
Biayna J, Mazuelas H, Gel B, Terribas E, Dumbovic G, Rosas I, Fernández-Rodriguez J, Blanco I, Castellanos E, Carrió M, Lazaro C, Serra E. Biayna J, et al. Sci Rep. 2021 Feb 11;11(1):3661. doi: 10.1038/s41598-021-83152-w. Sci Rep. 2021. PMID: 33574490 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous